Skip to main content
Galenica AG logo

Galenica AG — Investor Relations & Filings

Ticker · GALE ISIN · CH0360674466 LEI · 506700W4772BD8016Z20 SW Wholesale and retail trade
Open in API
Filings indexed 113 across all filing types
Latest filing 2026-04-27 Regulatory Filings
Country CH Switzerland
Listing SW GALE

About Galenica AG

https://www.galenica.com/en/index.php

Galenica AG is an integrated healthcare provider that operates a comprehensive network of companies. The group's core activities encompass pharmaceutical logistics and distribution, alongside the management of an extensive network of over 500 owned, joint venture, and partner pharmacies. Through its more than 20 business units, the company aims to deliver seamless, efficient, and personalized services to patients and customers. Galenica also develops digital healthcare solutions and offers a range of other healthcare services and products, positioning itself as a key partner in the healthcare market.

Recent filings

Filing Released Lang Actions
Healthcare players seek to establish the Electronic Prescription Switzerland service nationwide
Regulatory Filings Classification · 55% confidence The document is a corporate press release (media release) about a healthcare industry initiative to introduce an electronic prescription service in Switzerland. It does not present financial results or statutory reports (e.g., 10-K, IR, ER), nor does it announce board changes, dividends, share issues, M&A, or other specific transaction types. It is a general announcement, so it falls into the fallback category “Regulatory Filings (RNS).”
2026-04-27 English
Les acteurs du domaine de la santé veulent établir l’«E-Ordonnance Suisse» à l’échelle nationale
Regulatory Filings Classification · 20% confidence The document is a corporate press release via EQS News announcing a partnership initiative to roll out a digital e-prescription solution in Switzerland. It does not present financial results, regulatory filings, or detailed report content, and does not fit any specialized category (e.g., earnings release, annual report, M&A, governance, etc.). There is no dedicated “press release” category in the taxonomy, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-27 French
Healthcare players seek to establish the “Electronic Prescription Switzerland” service nationwide
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing a healthcare digitalisation initiative (“Electronic Prescription Switzerland”) by Galenica and industry partners. It contains general business information and is not a formal financial report (e.g., Annual Report, Earnings Release), not a shareholder meeting document, not regulatory stress‐test data, not a management change notice, and not a dividend or share transaction announcement. It does not publish a report itself but rather provides a narrative update, so it falls into the fallback category for miscellaneous regulatory announcements.
2026-04-27 English
Gesundheitsakteure wollen das «E-Rezept Schweiz» landesweit etablieren
Regulatory Filings Classification · 85% confidence The document is a media release (“Medienmitteilung”) by Galenica AG announcing the nationwide rollout of the “E-Rezept Schweiz” digital prescription system. It is not an earnings announcement, financial report, management change, capital action, or regulatory report but rather a general corporate press release. It does not fit any specific filing category (e.g., 10-K, IR, ER, DIV, M&A) and thus falls under the fallback category for miscellaneous regulatory/press announcements. Therefore, it is classified as a Regulatory Filing (RNS).
2026-04-27 German
Annual General Meeting of Galenica Ltd. passes all motions and approves dividend of CHF 2.50 per share
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release summarizing the outcome of the Annual General Meeting of Galenica Ltd. It details voting results (“passes all motions,” “re-elected all members,” “dividend approved”), which aligns with the Declaration of Voting Results & Voting Rights Announcements category. It is not the minutes themselves, nor a full annual report or earnings release, but an announcement of voting outcomes at the AGM.
2026-04-21 English
L’Assemblée générale de Galenica SA approuve toutes les propositions et décide de verser un dividende de CHF 2.50 par action
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release summarizing the outcome of the Annual General Meeting of Galenica SA, including approval of proposals, dividend resolution, board member reappointments, and formal vote results. It provides detailed voting outcomes and decisions from the AGM, matching the definition for a Declaration of Voting Results & Voting Rights Announcement, rather than the full annual report or other filing types.
2026-04-21 French

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.